NFKB1 and cholangiocarcinoma: While NF-κB plays dual roles in cancer, acting as both a cancer suppressor and promoter (Lalle, Twardowski & Grinberg-Bleyer, 2021), accumulating evidence indicates that its activation in CCA promotes cancer progression and may serve as a potential therapeutic target (Seubwai et al., 2014).